Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

NCT04617522 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumor
Liver Failure

Interventions

DRUG: Sacituzumab Govitecan-hziy

Sponsor

Gilead Sciences